S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Expanding Genetic Testing Beyond Specialty Clinics

Nephrologists and patient advocates gathered in Dallas last month to push genetic testing out of elite research centers and into everyday clinical practice. The National Kidney Foundation summit aimed to bridge the gap between rapidly evolving genomic science and the practical needs of community-based patients facing hereditary kidney conditions.

Expanding Genetic Testing Beyond Specialty Clinics
Photo: Bio & News

The two-day summit focused on demystifying genetic diagnostics for general nephrology practices. Experts argued that clinicians do not need specialized genetics training to act as advocates for their patients. By establishing simple workflows for informed consent, sample collection, and result interpretation, community providers can provide clearer diagnoses and better long-term management for families. Meyeon Park of UCSF noted that shifting this responsibility is essential to replacing clinical uncertainty with actionable information for both doctors and patients.

Beyond technical implementation, the event addressed the profound emotional toll of inherited disease. Patient speakers highlighted that genetic testing often affects entire families, requiring clinicians to consider the multi-generational trauma and socioeconomic barriers that prevent equitable access to care. Katie Reed, a transplant recipient and advocate, urged providers to look beyond test results and recognize the systemic disadvantages faced by rural and minority populations. As the field moves toward next-generation sequencing and polygenic risk scores, the National Kidney Foundation intends to use these insights to build resources that help clinicians translate complex biological data into personalized, accessible patient care.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!